|
CMV DNA+/DNA-
|
---|
|
UC
|
CD
|
---|
|
(161/28)
|
(29/8)
|
---|
Age
|
Number
|
P value
|
OR (95% CI)
|
Number
|
P value
|
OR (95% CI)
|
≤50 ys
|
117/22
|
0.514
|
0.725 (0.276 ~ 1.907)
|
18/6
|
0.685
|
0.545 (0.093 ~ 3.194)
|
>50 ys
|
44/6
| | |
11/2
| | |
Sex
| | | | | | |
male
|
95/14
|
0.373
|
1.439 (0.644 ~ 3.218)
|
19/4
|
0.445
|
1.900 (0.390 ~ 9.256)
|
female
|
66/14
| | |
10/4
| | |
Smoking
| | | | | | |
yes
|
40/5
|
0.423
|
1.521 (0.542 ~ 4.264)
|
7/2
|
1.000
|
0.840 (0.138 ~ 5.115)
|
no
|
121/23
| | |
25/6
| | |
Drinking
| | | | | | |
Yes
|
62/13
|
0.429
|
0.723 (0.322 ~ 1.621)
|
9/3
|
0.403
|
0.500 (0.100 ~ 2.510)
|
no
|
99/15
| | |
30/5
| | |
Diet composition
| | | | | | |
vegetarian food
|
15/3
|
1.000
|
0.856 (0.231 ~ 3.174)
|
3/3
|
0.101
|
0.192 (0.030 ~ 1.241)
|
mixed food
|
146/25
| | |
26/5
| | |
Fever
| | | | | | |
yes
|
30/2
|
0.221
|
2.977(0.670 ~ 13.235)
|
4/0
|
0.557
|
N/A
|
no
|
131/26
| | |
25/8
| | |
Hemoglobin(G/L)
| | | | | | |
≤70
|
8/1
|
1.000
|
1.412 (0.170 ~ 11.747)
|
0/0
|
-
|
N/A
|
>70
|
153/27
| | |
29/8
| | |
Albumin(G/L)
| | | | | | |
≤35
|
18/3
|
1.000
|
1.049 (0.288 ~ 3.826)
|
11/2
|
0.685
|
1.833 (0.313 ~ 10.735)
|
>35
|
143/25
| | |
18/6
| | |
Disease severity
| | | | | | |
mild and moderate
|
140/28
|
0.048*
|
N/A
|
24/6
|
0.631
|
1.600 (0.247 ~ 10.360)
|
severe
|
21/0
| | |
5/2
| | |
Location
| | | | | | |
distal colitis
|
123/17
|
0.080
|
2.094 (0.903 ~ 4.857)
| | | |
pancolitis
|
38/11
| | | | | |
ileal
| | | |
7/1
|
0.734
|
N/A
|
Colonic
| | | |
11/3
| | |
ileocolon
| | | |
11/4
| | |
Treatment
| | | | | | |
ASA/SASP
|
131/18
|
0.041*
|
2.426 (1.017 ~ 5.784)
|
19/1
|
0.014*
|
13.300 (1.429 ~ 123.790)
|
corticosteroids
|
45/2
|
0.035*
|
5.043 (1.149 ~ 22.128)
|
8/0
|
0.160
|
N/A
|
immunosuppressant
|
5/0
|
1.000
|
N/A
|
2/0
|
1.000
|
N/A
|
- CMV, cytomegalovirus; UC, ulcerative colitis; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
- *indicate significant difference.